Feminizing Treatment in Transgender Women and Non-binary Persons (BIC-Estrogen)

Odense University Hospital

Status: Enrolling

Conditions: Transgenderism

Treatments: Other: standard treatment

Study type: Observational

Funder types: Other

Identifiers

NCT05169762

BICTX03

Details and patient eligibility

About

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.

Full description

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years,

Outcomes:

Non-calcified and calcified plaque formation by contras coronary CT angiograms Heartfunction by ekko Cardiovaskular risk markers, f. eks. bp Markers of cardiovascular risk in blood and urine

Enrollment: 100 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• assigned male at birth and eligeble for gender affirming feminizing treatment

Exclusion criteria

none

Trial design

100 participants in 1 patient group

transgender women

Description:

transgender women eligeble to start gender affirming hormone treatment

Treatment:

Other: standard treatment